Sientra Inc (SIENQ)

OTCMKTS: SIENQ · Delayed Price · USD
0.211
0.00 (0.00%)
Mar 27, 2024, 12:00 AM EDT - Market open

Company Description

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally.

It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers.

It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007.

Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Sientra Inc
Sientra logo
Country United States
Founded 2006
IPO Date Oct 29, 2014
Industry Medical Devices
Sector Healthcare
Employees 304
CEO Jeffrey Nugent

Contact Details

Address:
3333 Michaelson Dr, Suite 650
Irvine, California 92612
United States
Phone 805-562-3500

Stock Details

Ticker Symbol SIENQ
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001551693
Employer ID 20-5551000
SIC Code 3842

Key Executives

Name Position
Ronald Menezes President, Chief Executive Officer and Director
Andrew C. Schmidt Senior Vice President, Treasurer and Chief Financial Officer
Oliver Christian Bennett Senior Vice President, Chief Legal, Compliance, and Corporate Development Officer
Keith J. Sullivan Director and Advisor to MiraDry Business
Caroline F. Van Hove Executive Chair of Board of Directors
Dr. Denise Dajles Chief Technical Officer
Mark S. Saxton Senior Vice President Sales
Adelle Walker Senior Vice President of Corporate Strategy and Marketing
Matt Hostetler Chief People Officer

Latest SEC Filings

Date Type Title
Feb 20, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 16, 2024 8-K Current Report
Feb 13, 2024 8-K Current Report
Feb 6, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Jan 29, 2024 8-K Current Report
Jan 16, 2024 8-K Current Report
Dec 20, 2023 8-K Current Report
Nov 13, 2023 10-Q Quarterly Report
Nov 9, 2023 8-K Current Report
Oct 31, 2023 8-K Current Report